IHT Wealth Management’s Leidos LDOS Stock Holding History

IHT Wealth Management’s Portfolio LDOS Stock Details LDOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-730	Closed	-$47K	–	941
2018 Q1	$47K	Buy	730 +400	+121%	+$26.4K	0.01%	697
2017 Q4	$22K	Buy	+330	New	+$20.7K	0.01%	962
2017 Q3	–	Sell	-1,122	Closed	-$15K	–	1492
2017 Q2	$15K	Buy	+1,122	New	+$59.7K	0.01%	851

Other funds holding LDOS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return

IHT Wealth Management's LDOS Position: Q2 2018 in Review

IHT Wealth Management sold out of Leidos (LDOS) in Q2 2018, closing a stake of 730 shares — an estimated $47K sold.

IHT Wealth Management first reported a position in LDOS in Q2 2017 and held it in 3 quarters. The position peaked at $47K in Q1 2018. 427 funds tracked by Wall St. Rank hold LDOS as of Q2 2018.

IHT Wealth Management reported no remaining Leidos position as of Q2 2018 after selling out during the quarter.
IHT Wealth Management sold 730 Leidos shares in Q2 2018, an estimated $47K.
IHT Wealth Management first reported a position in Leidos in Q2 2017 and held it in 3 quarters.
IHT Wealth Management's Leidos position peaked at $47K in Q1 2018.
427 funds tracked by Wall St. Rank held Leidos as of Q2 2018.

Based on IHT Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.